Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung cancer: Implications for stereotactic body radiation therapy-Reference-Cited by-同舟云学术

Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung cancer: Implications for stereotactic body radiation therapy

Published:2015-03 Issue:2 Volume:5 Page:79-84
ISSN:1879-8500
Container-title:Practical Radiation Oncology
language:en
Short-container-title:Practical Radiation Oncology

Author:

Pepek Joseph M.,Marks Lawrence B.,Berry Mark F.,Ready Neal E.,Gee Nathan G.,Coleman R. Edward,D’Amico Thomas A.,Crawford Jeffrey,Kelsey Chris R.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference22 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

2. Stereotactic body radiation therapy for inoperable early stage lung cancer;Timmerman;JAMA,2010

3. FDG-PET in staging lung cancer: How does it change the algorithm?;Verhagen;Lung Cancer,2004

4. Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer;Pozo-Rodríguez;J Clin Oncol,2005

5. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition);Detterbeck;Chest,2007

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Staging Workup and Staging System for Lung Cancer;Airway diseases;2023

2. Lung cancer staging: State of the art in the era of ablative therapies and surgical segmentectomy;Respirology;2020-04-22

3. Improving accuracy of hilar and lobar nodal staging in non-small cell lung cancer;Journal of Thoracic Disease;2019-05

4. The impact of training and professional collaboration on the interobserver variation of lung cancer delineations: a multi-institutional study;Acta Oncologica;2018-10-30

5. Effect of Endoscopic Bronchial Ultrasound on Outcomes for Stage I Non–Small-Cell Lung Cancer Patients Receiving Hypofractionated Radiotherapy;Clinical Lung Cancer;2018-03